NASDAQ
Nektar Therapeutics (NKTR) has a current ratio of 4.97x as of Monday, May 25, 2026. This represents a 29.07% decrease compared to its 12-month average of 7.01x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.